✦ LIBER ✦

Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder

✍ Scribed by Young-Min Park; Heon-Jeong Lee; Seung-Gul Kang; Chung-Sook Choo; Jae-Hyuck Cho

Book ID: 116841478
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 106 KB
Volume: 33
Category: Article
ISSN: 0278-5846
DOI: 10.1016/j.pnpbp.2008.12.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ORIGINAL RESEARCH—PSYCHOLOGY: Changes in

ORIGINAL RESEARCH—PSYCHOLOGY: Changes in Sexual Functioning Associated with Duloxetine, Escitalopram, and Placebo in the Treatment of Patients with Major Depressive Disorder

✍ Anita Clayton; Susan Kornstein; Apurva Prakash; Craig Mallinckrodt; Madelaine Wo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB

P.1.039 Long-term efficacy and safety of

P.1.039 Long-term efficacy and safety of venlafaxine ER in children and adolescents with major depressive disorder

✍ G.J. Emslie; P.P. Yeung; N.R. Kunz; Y. Li 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 215 KB

How long should a trial of escitalopram

How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

✍ David S. Baldwin; Dan J. Stein; Ornah T. Dolberg; Borwin Bandelow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective To extend the knowledge of course of improvement in patients with major depressive disorder (MDD), social anxiety disorder (SAD) or generalised anxiety disorder (GAD) participating in randomised placebo‐controlled trials (RCTs) and to infer the optimal duration of initial

P.2.c.023 Long-term safety and tolerabil

P.2.c.023 Long-term safety and tolerability of the multimodal antidepressant Lu AA21004 in subjects with major depressive disorder

✍ M. Alam; P.L. Jacobsen; Y. Chen; M. Serenko; A.R. Mahableshwarkar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Electroencephalographic sleep profiles i

Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX/CRH-test response

✍ Martin Hatzinger; Ulrich M. Hemmeter; Serge Brand; Marcus Ising; Edith Holsboer- 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Neuroendocrine, biochemical and pharmaco

Neuroendocrine, biochemical and pharmacokinetic effects of a long-term treatment with the selective serotonin reuptake inhibitor (SSRI) citalopram in major depressive disorder

✍ G. Nikisch; A. Czernik; A.A. Mathé; J. Diegmann; M. Amey; P. Baumann 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 149 KB